학술논문
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer
Document Type
Article
Author
Source
In: Clinical Genitourinary Cancer . (Clinical Genitourinary Cancer, June 2023, 21(3):366-375)
Subject
Language
English
ISSN
19380682
15587673
15587673